Search

Displaying results 6351 - 6360 of 10000 in total
  1. Drug

    Lofentanil

    go.drugbank.com/drugs/DB09174
    ExperimentalIllicit

    Lofentanil is an analog of fentanyl and is one of the most potent opioids available today.

  2. Drug

    Dexpemedolac

    go.drugbank.com/drugs/DB19987
    Experimental

    Dexpemedolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Dexpemedolac is a anti-inflammatory agent, ibufenac derivative. … Dexpemedolac has a monoisotopic molecular weight of 349.17 Da.

  3. Drug

    Isofezolac

    go.drugbank.com/drugs/DB20228
    Experimental

    Isofezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Isofezolac is a anti-inflammatory agent, ibufenac derivative. … Isofezolac has a monoisotopic molecular weight of 354.14 Da.

  4. Drug

    Clopirac

    go.drugbank.com/drugs/DB20824
    Experimental

    Clopirac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Clopirac is a anti-inflammatory agent, ibufenac derivative. … Clopirac has a monoisotopic molecular weight of 263.07 Da.

  5. Drug

    AGS-16C3F

    go.drugbank.com/drugs/DB17551
    Investigational

    AGS 16C3F is an intravenously administered, anti-ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) antibody-drug conjugate. … AGS-16C3F is under investigation in clinical trial NCT02639182 (A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma).

  6. Drug

    EGT-101

    go.drugbank.com/drugs/DB17645
    Experimental

    Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type A.[L45919] … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the human sulfamidase (SGSH) transgene.

  7. Drug

    CoronaVac

    go.drugbank.com/drugs/DB15806
    Investigational

    CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation[A219758]. … As of August 2020, the vaccine is being tested in numerous human clinical trials assessing its safety and immunogenicity.

  8. Drug

    LetibotulinumtoxinA

    go.drugbank.com/drugs/DB16820
    Approved

    [L42330] It is a 900 kDa multimeric complex comprising a 150 kDa toxin, a 130 kDa non-toxic non-haemagglutinating protein, and various other haemagglutinins. … [A249920] LetibotulinumtoxinA is a type A botulinum neurotoxin produced from fermentation of _Clostridium botulinum_ strain CBFC26.

    Categories: Botulinum Toxins, Type ASynonyms: BoNT/A-DS
  9. Drug

    Vedolizumab

    go.drugbank.com/drugs/DB09033
    ApprovedInvestigational

    Vedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation implicated in diseases like ulcerative … [A261576] Vedolizumab is administered by IV infusion over a period of 30 minutes; after the first dose, it is given again at two and six weeks and then every 8 weeks thereafter.

    Categories: Integrin Receptor Antagonist
  10. Drug

    CT-011

    go.drugbank.com/drugs/DB05916
    Investigational

    CT-011 is a humanized monoclonal antibody directed against a B7 family-associated protein, in patients with advanced haematological malignancies.